May 13, 2016
A Halifax-led study could lead to better life-saving treatment for people suffering from a deadly heart condition. The clinical trial involved 259 patients at 22 medical centres around the world who suffer from a condition known as ventricular tachycardia, which can result in a dangerous, abnormal heart rhythm and affects about 50,000 Canadians. Heart attacks...
Read More

About CANet

CANet is a Pan-Canadian multidisciplinary and multi-sectoral research and development network of investigators, well-positioned industry partners, patients, caregivers, and healthcare providers focused on arrhythmia research, technology development and commercialization, and digital transformation activities.